Hormone Replacement Therapy Comprising an Oestrogen-Progestogen Combination for Menopausal and Postmenopausal
Multiple Choice
Hormone replacement therapy comprising an oestrogen-progestogen combination for menopausal and postmenopausal women has been found to:
A) be inappropriate for the short-term relief associated with the clinical manifestations of the menopause.
B) lower the risk of cardiovascular disease in postmenopausal women.
C) reduce the relative risk of osteoporosis and colon cancer but increase the risk of breast cancer and thromboembolism for postmenopausal women receiving therapy.
D) be safer than the use of a selective oestrogen receptor modulator in the management of osteoporosis.
Correct Answer:

Verified
Correct Answer:
Verified
Q1: Women treated with oestrogen-only preparations may be
Q2: The AAS nandrolone may be used in
Q4: To ensure maximum efficacy for postcoital contraception,it
Q5: Which one of the gonadal hormones induces
Q6: What is the efficacy rate for emergency
Q7: An adverse effect NOT associated with androgenic
Q8: A major consideration associated with the progestogen-only
Q9: The SERM tamoxifen is used in the